Search Results

The ABL837 FLEX analyzer is intended for in vitro testing of samples of heparinized whole blood, plasma and serum for the parameter Creatinine measurements measurements measure the concentration of creatinine in blood. Creatinine measurements are used in the diagnosis and treatment of renal diseases and in monitoring renal dialysis.

The ABL837 FLEX is an analyzer with the capability of measuring creatinine. The wet section of the ABL837 FLEX analyzer is structured as the wet section of the ABL800 FLEX and ABL800 FLEX with FLEXQ Module analyzers, but includes a measuring module comprising the measurement system for the creatinine parameter. This measuring system compissing electrodes, one of which measures creatine and the other of which measures creating and creatinine. The creatinine parameter value is determined as a difference measure of the output of these two new electrodes. The two electrodes are developed based on the concept of the existing Radiometer Medical ApS glucose and lactate electrodes. The sensors for measuring creatinine are electrochemical sensors.

Here's an analysis of the provided text regarding the ABL837 FLEX device, focusing on the acceptance criteria and study information:

1. A table of acceptance criteria and the reported device performance

The provided text does not explicitly state numerical acceptance criteria for the ABL837 FLEX. Instead, it describes a "comparison test" against a predicate device and states that the ABL837 FLEX performed "equivalent" to that device.

The device also demonstrated:LinearityPrecisionDetection limitsInterference (presumably acceptable levels) |

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

• Sample Size for Test Set: Not specified in the provided document.
• Data Provenance: Not specified. It does not mention the country of origin of the data or whether the study was retrospective or prospective.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

This section is not applicable to this type of device and study. The ABL837 FLEX is an in vitro diagnostic device for measuring creatinine. Ground truth for such devices is typically established through reference methods, calibrated standards, or comparison to an established, legally marketed predicate device, rather than expert consensus on image interpretation or similar qualitative assessments.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

This section is not applicable. Adjudication methods like 2+1 or 3+1 are typically used for studies involving human interpretation (e.g., medical imaging) where there might be disagreement among readers on a diagnosis or finding. For an objective measurement device like the ABL837 FLEX, performance is evaluated by comparing its output to a known standard or a predicate device.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

No, an MRMC comparative effectiveness study was not done, and this type of study is not applicable here. MRMC studies are used to evaluate human reader performance, often in diagnostic imaging, and to assess the impact of AI assistance on that performance. The ABL837 FLEX is an automated analyzer, not an AI system assisting human readers.

6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

Yes, a "standalone" or algorithm-only performance assessment was done. The "Performance Test" section describes tests performed directly on the ABL837 FLEX analyzer (linearity, precision, detection limits, interference, and comparison to the predicate device). As a fully automated analyzer, its performance is inherently standalone.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

The ground truth for the comparison test was the i-STAT System Creatinine Test, which is a legally marketed predicate device (K973292). For linearity, precision, and detection limits, the ground truth would typically be established using calibrated reference materials or gold-standard laboratory methods. The document doesn't explicitly detail the specific gold standards used for these individual tests, but the overall claim of "equivalence" is relative to the i-STAT device.

8. The sample size for the training set

Not applicable/Not mentioned. This device does not use machine learning in a way that would typically involve a "training set" in the context of AI algorithms. It is an electrochemical sensor-based analyzer.

9. How the ground truth for the training set was established

Not applicable. As stated above, there is no mention of a training set for this type of device.

Ask a specific question about this device